TARANTINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 51.942
AS - Asia 35.927
EU - Europa 16.608
AF - Africa 6.464
SA - Sud America 6.244
OC - Oceania 590
Continente sconosciuto - Info sul continente non disponibili 279
Totale 118.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.346
SG - Singapore 10.812
CN - Cina 5.895
VN - Vietnam 4.840
IT - Italia 3.788
HK - Hong Kong 3.775
BR - Brasile 3.701
BD - Bangladesh 1.747
FR - Francia 1.356
DE - Germania 1.198
FI - Finlandia 1.183
IN - India 1.167
PL - Polonia 896
GB - Regno Unito 828
SE - Svezia 810
IQ - Iraq 624
RU - Federazione Russa 618
NL - Olanda 586
AR - Argentina 559
JP - Giappone 546
TR - Turchia 529
CA - Canada 490
UA - Ucraina 450
PK - Pakistan 406
PH - Filippine 403
ZA - Sudafrica 381
MX - Messico 364
KR - Corea 348
SA - Arabia Saudita 348
ID - Indonesia 337
EC - Ecuador 328
ES - Italia 312
AT - Austria 299
CO - Colombia 296
IE - Irlanda 275
UZ - Uzbekistan 275
MA - Marocco 260
VE - Venezuela 255
JM - Giamaica 251
MY - Malesia 235
CL - Cile 231
EG - Egitto 230
AO - Angola 225
CI - Costa d'Avorio 218
TN - Tunisia 216
PY - Paraguay 210
GR - Grecia 207
JO - Giordania 207
ET - Etiopia 205
KE - Kenya 204
TH - Thailandia 203
AE - Emirati Arabi Uniti 202
PE - Perù 198
AL - Albania 191
NP - Nepal 191
AZ - Azerbaigian 187
CH - Svizzera 187
DZ - Algeria 187
DO - Repubblica Dominicana 182
LB - Libano 181
BE - Belgio 180
MD - Moldavia 180
BJ - Benin 179
GT - Guatemala 175
PS - Palestinian Territory 173
IR - Iran 172
KZ - Kazakistan 172
RS - Serbia 172
UY - Uruguay 172
AU - Australia 169
HN - Honduras 168
LV - Lettonia 167
MK - Macedonia 166
NI - Nicaragua 166
CZ - Repubblica Ceca 165
PT - Portogallo 165
HU - Ungheria 164
RO - Romania 164
TT - Trinidad e Tobago 164
MG - Madagascar 163
PA - Panama 161
BO - Bolivia 160
CR - Costa Rica 160
SK - Slovacchia (Repubblica Slovacca) 160
CM - Camerun 159
IL - Israele 158
SN - Senegal 157
TW - Taiwan 156
BY - Bielorussia 154
GN - Guinea 154
SI - Slovenia 154
YT - Mayotte 154
BB - Barbados 153
CV - Capo Verde 152
CW - ???statistics.table.value.countryCode.CW??? 152
PR - Porto Rico 151
NO - Norvegia 149
BA - Bosnia-Erzegovina 148
LA - Repubblica Popolare Democratica del Laos 147
MZ - Mozambico 147
Totale 110.661
Salva come PNG Salva come JPEG
Città #
Singapore 6.430
Ashburn 6.349
San Jose 5.767
Fairfield 4.656
Hong Kong 3.422
Woodbridge 2.524
Chandler 2.515
Houston 2.140
Seattle 1.686
Cambridge 1.662
Wilmington 1.568
Santa Clara 1.500
Ann Arbor 1.471
Ho Chi Minh City 1.453
Beijing 1.147
Hanoi 1.109
Los Angeles 964
Jacksonville 927
Boardman 912
Lauterbourg 692
Princeton 658
New York 615
San Diego 614
Helsinki 582
Bytom 573
Medford 492
Roxbury 376
Padova 358
São Paulo 357
Tokyo 357
Des Moines 341
Chicago 328
Milan 318
Hefei 295
Buffalo 294
Da Nang 291
Nanjing 289
Rome 276
Munich 264
Orem 262
Council Bluffs 233
Tashkent 233
Baghdad 232
Abidjan 212
Dublin 210
Dong Ket 196
Haiphong 196
London 196
Seoul 195
Guangzhou 190
Dallas 188
Luanda 185
Amman 184
Vienna 181
Baku 173
Warsaw 172
Johannesburg 168
Addis Ababa 167
Nairobi 166
Cotonou 162
Brooklyn 157
Kingston 156
Managua 156
Dakar 152
Conakry 151
Istanbul 150
Atlanta 149
Montreal 149
Panama City 149
Frankfurt am Main 148
Antananarivo 144
Bridgetown 142
Riga 141
Montevideo 140
Chennai 135
Libreville 135
Ulan Bator 135
Turku 133
San José 128
Jeddah 127
Stockholm 127
Vientiane 127
Castries 126
Phnom Penh 126
Andorra la Vella 125
Denver 125
Kampala 125
Lima 124
Nassau 124
Nuremberg 124
Bishkek 122
Dushanbe 122
Nouakchott 120
Harare 119
Accra 118
Bamako 118
Kuala Lumpur 118
Lahore 118
Praia 118
Willemstad 118
Totale 65.994
Salva come PNG Salva come JPEG
Nome #
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial 422
2017 ESC/EACTS Guidelines for the management of valvular heart disease 367
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 348
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 347
3D-printing model for complex aortic transcatheter valve treatment 321
Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation 320
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 301
At-admission risk stratification for in-hospital life-threatening ventricular arrhythmias and death in non-ST elevation myocardial infarction patients. 298
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 292
Acute decompensated heart failure in young woman with lymphoproliferative disorder 289
Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens’ ECG pattern) in Tako-Tsubo cardiomyopathy 287
Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement 287
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 286
Association Between Common Cardiovascular Risk Factors and Clinical Phenotype in Patients with Hypertrophic Cardiomyopathy From the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis Registry 286
Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography. 285
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 282
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. 279
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 277
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies 271
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 270
[Impact of COVID-19 pandemic on structural heart interventions in Italy] 267
Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis. 266
Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance. 265
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 265
Definition of trAnscatheter heart Valve orIeNtation in biCuspId aortic valve: The DA VINCI pilot study 264
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 262
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 262
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 262
Coronary vasospasm complicated by ventricular fibrillation: arrhythmogenic morphological substrates detected in vivo by cardiac magnetic resonance. 260
Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest 259
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 259
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE) 259
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris 257
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 256
'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up 256
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study 253
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 253
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 252
Early and Midterm Clinical and Hemodynamic Outcomes of Transcatheter Valve-in-Valve Implantation: Results From a Multicenter Experience 252
Another passenger for the TAVR speeding train 252
LAD coronary artery myocardial bridging and apical ballooning syndrome. 251
Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study. 248
Left Atrial Expansion Index for Noninvasive Estimation of Pulmonary Capillary Wedge Pressure: A Cardiac Catheterization Validation Study 245
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 244
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 243
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 243
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. 242
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 242
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 241
"in-house" pharmacological management for computed tomography coronary angiography: Heart rate reduction, timing and safety of different drugs used during patient preparation 241
SICI-GISE Position paper on the use of the magnesium bioresorbable scaffold Magmaris in clinical practice 241
Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. 240
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern 240
Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI? 240
Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Cardiac Allograft Vasculopathy 238
Relation of aortic valve weight to severity of aortic stenosis. 238
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 238
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. 236
Impact of type of intervention for aortic valve replacement on heart rate variability 236
Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry 236
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 235
Impact of Pulmonary Hypertension on Outcomes after Transcatheter Tricuspid Valve Edge-to-Edge Repair 235
Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty 234
Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 233
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 233
Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery 233
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 233
Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: a propensity weighted study. 232
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 232
Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation 231
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 230
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 230
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. 229
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experience. 229
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 228
Myocardial substrates underlying early ventricular arrhythmias in ST-elevation acute myocardial infarction: the role of cardiac magnetic resonance 228
Cardiac Magnetic Resonance Features of Biopsy-Proven Endomyocardial Diseases. 228
Transcatheter mitral valve repair with MitraClip: comparison of NT, NTr, and XTr Devices 227
Management and Outcome of Failed Percutaneous Edge-to-Edge Mitral Valve Plasty: Insight From an International Registry 227
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 226
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome 226
Relationship between CHA2DS2-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome 226
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413) 226
Cardiac arrest due to acute massive aortic root thrombosis after pericardial bioprosthetic aortic valve replacement 226
Monitoring patients reported outcomes after valve replacement using wearable devices: Insights on feasibility and capability study: Feasibility results 225
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 225
Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension 224
Patent foramen ovale closure and migraine time course: Clues for positive interaction 223
Apico-Basal Gradient Of Left Ventricular Myocardial Edema Underlies Transient T-Wave Inversion And Qt Interval Prolongation (Wellens' Ecg Pattern) In Tako-Tsubo Cardiomyopathy. 223
The electrocardiographic "triangular QRS-ST-T waveform" pattern in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology and clinical implications 223
The SAPIEN 3 valve: lights and shadows. 222
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 222
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 222
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 220
PCI Versus CABG for Multivessel Coronary Disease in Diabetics 218
Low Serum Testosterone as a New Risk Factor for Chronic Rejection in Heart Transplanted Men 218
The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation 218
Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. 217
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 216
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 216
Totale 25.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 343.239
article - articoli 335.017
book - libri 779
conference - conferenze 0
curatela - curatele 0
other - altro 288
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.354
Totale 682.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.564 176 819 873 507 321 601 308 813 693 196 598 1.659
2022/20235.365 1.110 535 142 613 772 586 19 331 558 123 256 320
2023/20243.315 146 424 330 252 273 265 254 202 232 133 373 431
2024/202515.230 265 1.047 636 522 1.900 551 662 1.210 1.348 689 2.427 3.973
2025/202668.676 2.678 5.163 9.819 11.425 5.914 3.015 8.566 5.805 6.779 3.758 3.091 2.663
2026/20271.714 1.714 0 0 0 0 0 0 0 0 0 0 0
Totale 118.948